| Nausheen Abbas, MD | |
|
205 Valley Ave, West Bend, WI 53095-5312 | |
| (262) 338-1123 | |
| Not Available |
| Full Name | Nausheen Abbas |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 15 Years |
| Location | 205 Valley Ave, West Bend, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356665236 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 60476393 (Washington) | Secondary |
| 207W00000X | Ophthalmology | 64565-20 (Wisconsin) | Primary |
| 207W00000X | Ophthalmology | 268882 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Medical Ctr Washington County | Hartford, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Advanced Healthcare Inc | 3375625833 | 929 |
News Archive
Genzyme Corporation today provided an extensive briefing on the market potential of alemtuzumab for multiple sclerosis at an event for investors and analysts in New York.
Once again, the National Bipolar Foundation and the MedicAlert Foundation receive a proclamation endorsing their "Safe 'til Stable" program, which is now being widely accepted as a preventive health care measure for bipolar disorder.
Canada has the opportunity to be an international leader in personalized medicine and needs to invest in this area for the health of Canadians and to reap the benefits of job creation, writes Dr. Thomas Hudson in a commentary http://www.cmaj.ca/cgi/rapidpdf/cmaj.1090199 released online today in CMAJ ( Canadian Medical Association Journal ).
In a study to determine the diagnostic value of molecular imaging in nodal staging of patients with thyroid cancer, researchers were able for the first time to accurately distinguish between cancerous cells in regional lymph nodes and normal residual thyroid tissue directly after surgery.
› Verified 9 days ago
| Entity Name | Aurora Advanced Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
Genzyme Corporation today provided an extensive briefing on the market potential of alemtuzumab for multiple sclerosis at an event for investors and analysts in New York.
Once again, the National Bipolar Foundation and the MedicAlert Foundation receive a proclamation endorsing their "Safe 'til Stable" program, which is now being widely accepted as a preventive health care measure for bipolar disorder.
Canada has the opportunity to be an international leader in personalized medicine and needs to invest in this area for the health of Canadians and to reap the benefits of job creation, writes Dr. Thomas Hudson in a commentary http://www.cmaj.ca/cgi/rapidpdf/cmaj.1090199 released online today in CMAJ ( Canadian Medical Association Journal ).
In a study to determine the diagnostic value of molecular imaging in nodal staging of patients with thyroid cancer, researchers were able for the first time to accurately distinguish between cancerous cells in regional lymph nodes and normal residual thyroid tissue directly after surgery.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nausheen Abbas, MD 205 Valley Ave, West Bend, WI 53095-5312 Ph: (262) 338-1123 | Nausheen Abbas, MD 205 Valley Ave, West Bend, WI 53095-5312 Ph: (262) 338-1123 |
News Archive
Genzyme Corporation today provided an extensive briefing on the market potential of alemtuzumab for multiple sclerosis at an event for investors and analysts in New York.
Once again, the National Bipolar Foundation and the MedicAlert Foundation receive a proclamation endorsing their "Safe 'til Stable" program, which is now being widely accepted as a preventive health care measure for bipolar disorder.
Canada has the opportunity to be an international leader in personalized medicine and needs to invest in this area for the health of Canadians and to reap the benefits of job creation, writes Dr. Thomas Hudson in a commentary http://www.cmaj.ca/cgi/rapidpdf/cmaj.1090199 released online today in CMAJ ( Canadian Medical Association Journal ).
In a study to determine the diagnostic value of molecular imaging in nodal staging of patients with thyroid cancer, researchers were able for the first time to accurately distinguish between cancerous cells in regional lymph nodes and normal residual thyroid tissue directly after surgery.
› Verified 9 days ago
Paul R Rice, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5345 Quaas Dr, West Bend, WI 53095 Phone: 262-338-8826 Fax: 262-334-3237 | |
Dr. Earl William Nepple, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1201 Oak Street, West Bend, WI 53095 Phone: 262-338-0505 Fax: 262-338-0807 |